Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Bicycle Therapeutics plc

< Previous 1 2 3 Next >
News headline image
Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
News headline image
Bicycle Therapeutics Enhances Leadership Team with Key Appointments
From Bicycle Therapeutics plc
Via Business Wire
Tickers BCYC
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.